%A Chen,Yu-Jhen %A Lin,Ying-Jui %A Guo,Mindy Ming-Huey %D 2022 %J Frontiers in Pediatrics %C %F %G English %K Lupus (SLE),Myocarditis,Pulmonary arterial hypertension (PAH),Children,Pericardial effusion (PE) %Q %R 10.3389/fped.2022.772422 %W %L %M %P %7 %8 2022-January-26 %9 Case Report %# %! lupus myocarditis and pulmonary hypertension %* %< %T Pediatric Lupus Presenting as Pulmonary Hypertension, Myocarditis, and Massive Pericardial Effusion in an 11-Year-Old Girl: A Case Report and Literature Review %U https://www.frontiersin.org/articles/10.3389/fped.2022.772422 %V 10 %0 JOURNAL ARTICLE %@ 2296-2360 %X Systemic lupus erythematosus (SLE) is an autoimmune disease that may cause vital organ damage. Although not rare for child-onset SLE to have cardiovascular or pulmonary involvement, myocarditis, and pulmonary hypertension are infrequent features and can be life-threatening. In this case report, we describe an 11-year-old girl with SLE who initially presented with fulminant myocarditis pulmonary hypertension, and massive pericardial effusion. Initial immunosuppressive therapy with methylprednisolone pulse therapy, and IVIG were administered, followed by cyclophosphamide, which was ultimately successful, with no residual pulmonary hypertension and no recurrence of myocarditis for over 3 years after the initial episode. Our case highlights the need for clinicians to be aware of systemic lupus erythematosus as a possible diagnostic entity in pediatric patients with severe myocarditis or pulmonary hypertension. Aggressive immunosuppressive therapy should be strongly considered in such cases, as it may lead to good short-term and long-term outcomes.